| ARE | antioxidant response elements |
| BZF | 2-(benzoyl)-2-hydroxy-3(2H)-benzofuranone derivative(s) |
| Caco-2 | human colonic adenocarcinoma |
| CAT | catalase |
| CYP | cytochrome P450 |
| DPPH | 2,2-diphenyl-1-picrylhydrazyl |
| EpRE | electrophile response elements |
| FITC dextran | 3–5-kDa dextran conjugated with fluorescein isothiocyanate |
| Ɣ-Glu–Cys ligase | gamma glutamate–cysteine ligase |
| GI | gastrointestinal |
| GSH | reduced glutathione |
| GSHpx | glutathione peroxidase |
| GSSGred | glutathione reductase |
| HO-1 | heme oxygenase-1 |
| Keap1 | Kelch-like ECH-associated protein 1 |
| NF-κB | nuclear factor kappa B |
| NQO1 | NAD(P)H:quinone oxidoreductase 1 |
| Nrf2-Keap1 | nuclear factor (erythroid-derived 2)-like 2 |
| NSAID | non-steroidal anti-inflammatory drugs |
| OAE | onion peel aqueous extract |
| PKC | protein kinase C |
| PKCζ | protein kinase C zeta type |
| Q-BZF | 2-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-3(2H)-benzofuranone |
| Qox | quercetin oxidation mixture |
| ROS | reactive oxygen species |
| SOD | superoxide dismutase |
| TEER | transepithelial electrical resistance |